三闯港交所终圆梦,开盘暴涨152%!健康160的“规模神话”与盈利困局

医药研究社
Sep 18

健康160的上市只是起点。来源|医药研究社事不过三,健康160终于等到了港交所亮绿灯。据悉,健康160曾于2023年12月、2024年10月、2025年6月先后三次递表,在港交所徘徊了两年左右时间也终于圆梦了。就在昨日,该公司敲钟上市,开盘股价涨幅152.14%,报29.98港元/股,收盘股价涨幅137.34%,报28.22港元/股,市值达到94.95亿港元。从这样的首发表现来看,健康160已经...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10